• Most Popular
  • Most Shared

UPDATE 4-Cell Therapeutics drug draws US FDA staff concerns

Mon Feb 8, 2010 4:43pm EST

* FDA staff raise issues with safety, effectiveness

* Pixantrone to be reviewed by advisory panel Wednesday

* Company says drug works, side effects manageable

* Shares fall nearly 40 pct (Updates shares, adds details on Novartis option)

By Lisa Richwine